Plasmodium falciparum protein microarray antibody profiles correlate with protection from symptomatic malaria in Kenya

Journal of Infectious Diseases

Volumn 212, Issue 9, 2015, Pages 1429-1438

  Dent, Arlene E ^a,b   Nakajima, Rie ^c   Liang, Li ^c   Baum, Elisabeth ^c   Moormann, Ann M ^d   Sumba, Peter Odada ^f   Vulule, John ^f   Babineau, Denise ^e   Randall, Arlo ^g   Davies, D Huw ^c   Felgner, Philip L ^c   Kazura, James W ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^e RHO INC   (United States)

^f KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^g Antigen Discovery Inc   (United States)

Author keywords

antibody; antigen; malaria; protective immunity; protein microarray

Indexed keywords

70KD EMP1 TRAFFICKING PROTEIN; ARTEMETHER PLUS BENFLUMETOL; ERYTHROCYTE MEMBRANE PROTEIN 1; IMMUNOGLOBULIN G ANTIBODY; LIVER STAGE ANTIGEN 3; MEROZOITE SURFACE PROTEIN 10; MEROZOITE SURFACE PROTEIN 2; MEROZOITE SURFACE PROTEIN 7; PARASITE ANTIGEN; PLASMODIUM FALCIPARUM PROTEIN; PLASMODIUM HELICAL INTERSPERSED SUBTELOMERIC DOMAIN PROTEIN; PROTOZOAL PROTEIN; UNCLASSIFIED DRUG; ANTIMALARIAL AGENT; ERYTHROCYTE MEMBRANE PROTEIN 1, PLASMODIUM FALCIPARUM; IMMUNOGLOBULIN G; MEMBRANE PROTEIN; PROTOZOON ANTIBODY;

ADAPTIVE IMMUNITY; ADOLESCENT; ADULT; AGE; AGED; ANTIBODY RESPONSE; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; ASYMPTOMATIC INFECTION; CHILD; CONTROLLED STUDY; CORRELATIONAL STUDY; HUMAN; INFECTION RATE; KENYA; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; NONHUMAN; PLASMODIUM FALCIPARUM; PREDICTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN MICROARRAY; REINFECTION; SEROCONVERSION; SYMPTOMATIC MALARIA; ANIMAL; BLOOD; FEMALE; GENETICS; IMMUNOLOGY; INFANT; INNATE IMMUNITY; ISOLATION AND PURIFICATION; MALARIA; MEROZOITE; MIDDLE AGED; MOUSE; PROPORTIONAL HAZARDS MODEL; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNITY, INNATE; IMMUNOGLOBULIN G; INFANT; KENYA; MALARIA; MEMBRANE PROTEINS; MEROZOITES; MICE; MIDDLE AGED; PLASMODIUM FALCIPARUM; PROPORTIONAL HAZARDS MODELS; PROTEIN ARRAY ANALYSIS; PROTOZOAN PROTEINS; YOUNG ADULT;

EID: 84946136495     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv224     Document Type: Article

References (37)

1. Alonso PL, Tanner M. Public health challenges and prospects for malaria control and elimination. Nat Med 2013; 19: 150-5
2. Crompton PD, Moebius J, Portugal S, et al. Malaria immunity in man and mosquito: insights into unsolved mysteries of a deadly infectious disease. Annu Rev Immunol 2014; 32: 157-87
3. Langhorne J, Ndungu FM, Sponaas AM, Marsh K. Immunity to malaria: more questions than answers. Nat Immunol 2008; 9: 725-32
4. Doolan DL, Mu Y, Unal B, et al. Profiling humoral immune responses to P. falciparum infection with protein microarrays. Proteomics 2008; 8: 4680-94
5. Tsuboi T, Takeo S, Iriko H, et al. Wheat germ cell-free system-based production of malaria proteins for discovery of novel vaccine candidates. Infect Immun 2008; 76: 1702-8
6. Moormann AM, Sumba PO, Chelimo K, et al. Humoral and cellular immunity to Plasmodium falciparum merozoite surface protein 1 and protection from infection with blood-stage parasites. J Infect Dis 2013; 208: 149-58
7. Pinkevych M, Petravic J, Chelimo K, Kazura JW, Moormann AM, Davenport MP. The dynamics of naturally acquired immunity to Plasmodium falciparum infection. PLoS Comput Biol 2012; 8: e1002729
8. Pinkevych M, Petravic J, Chelimo K, et al. Density-dependent blood stage Plasmodium falciparum suppresses malaria super-infection in a malaria holoendemic population. Am J Trop Med Hyg 2013; 89: 850-6
9. Pinkevych M, Petravic J, Chelimo K, et al. Decreased growth rate of P. falciparum blood stage parasitemia with age in a holoendemic population. J Infect Dis 2014; 209: 1136-43
10. Crompton PD, Kayala MA, Traore B, et al. A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray. Proc Natl Acad Sci USA 2010; 107: 6958-63
11. Felgner PL, Roestenberg M, Liang L, et al. Pre-erythrocytic antibody profiles induced by controlled human malaria infections in healthy volunteers under chloroquine prophylaxis. Sci Rep 2013; 3: 3549
12. Nnedu ON, O Leary MP, Mutua D, et al. Humoral immune responses to Plasmodium falciparum among HIV-1-infected Kenyan adults. Proteomics Clin Appl 2011; 5: 613-23
13. Sundaresh S, Doolan DL, Hirst S, et al. Identification of humoral immune responses in protein microarrays using DNA microarray data analysis techniques. Bioinformatics 2006; 22: 1760-6
14. Goeman JJ, Oosting J, Cleton-Jansen AM, Anninga JK, van Houwelingen HC. Testing association of a pathway with survival using gene expression data. Bioinformatics 2005; 21: 1950-7
15. Baldi P, Long AD. A Bayesian framework for the analysis of microarray expression data: regularized t -test and statistical inferences of gene changes. Bioinformatics 2001; 17: 509-19
16. Drakeley CJ, Corran PH, Coleman PG, et al. Estimating medium-and long-term trends in malaria transmission by using serological markers of malaria exposure. Proc Natl Acad Sci USA 2005; 102: 5108-13
17. Florens L, Washburn MP, Raine JD, et al. A proteomic view of the Plasmodium falciparum life cycle. Nature 2002; 419: 520-6
18. Tarun AS, Peng X, Dumpit RF, et al. A combined transcriptome and proteome survey of malaria parasite liver stages. Proc Natl Acad Sci USA 2008; 105: 305-10
19. Smith JD, Rowe JA, Higgins MK, Lavstsen T. Malaria s deadly grip: cytoadhesion of Plasmodium falciparum-infected erythrocytes. Cell Microbiol 2013; 15: 1976-83
20. Greenhouse B, Ho B, Hubbard A, et al. Antibodies to Plasmodium falciparum antigens predict a higher risk of malaria but protection from symptoms once parasitemic. J Infect Dis 2011; 204: 19-26
21. Gondeau C, Corradin G, Heitz F, et al. The C-terminal domain of Plasmodium falciparum merozoite surface protein 3 self-assembles into alpha-helical coiled coil tetramer. Mol Biochem Parasitol 2009; 165: 153-61
22. Pearce JH, Mills K, Triglia T, Cowman AF, Anders RF. Characterisation of two novel proteins from the asexual stage of Plasmodium falciparum, H101 and H103. Mol Biochem Parasitol 2005; 139: 141-51
23. Osier FH, Mackinnon MJ, Crosnier C, et al. New antigens for a multicomponent blood-stage malaria vaccine. Sci Transl Med 2014; 6: 247ra102
24. Richards JS, Arumugam TU, Reiling L, et al. Identification and prioritization of merozoite antigens as targets of protective human immunity to Plasmodium falciparum malaria for vaccine and biomarker development. J Immunol 2013; 191: 795-809
25. Crompton PD, Pierce SK, Miller LH. Advances and challenges in malaria vaccine development. J Clin Invest 2010; 120: 4168-78
26. Cummings JF, Spring MD, Schwenk RJ, et al. Recombinant liver stage antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection. Vaccine 2010; 28: 5135-44
27. Daubersies P, Thomas AW, Millet P, et al. Protection against Plasmodium falciparum malaria in chimpanzees by immunization with the conserved pre-erythrocytic liver-stage antigen 3. Nat Med 2000; 6: 1258-63
28. Genton B, Betuela I, Felger I, et al. A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea. J Infect Dis 2002; 185: 820-7
29. Heiber A, Kruse F, Pick C, et al. Identification of new PNEPs indicates a substantial non-PEXEL exportome and underpins common features in Plasmodium falciparum protein export. PLoS Pathog 2013; 9: e1003546
30. Barry AE, Trieu A, Fowkes FJ, et al. The stability and complexity of antibody responses to the major surface antigen of Plasmodium falciparum are associated with age in a malaria endemic area. Mol Cell Proteomics 2011; 10: M111.008326
31. Beck JR, Muralidharan V, Oksman A, Goldberg DE. PTEX component HSP101 mediates export of diverse malaria effectors into host erythrocytes. Nature 2014; 511: 592-5
32. De Koning-Ward TF, Gilson PR, Boddey JA, et al. A newly discovered protein export machine in malaria parasites. Nature 2009; 459: 945-9
33. Elsworth B, Matthews K, Nie CQ, et al. PTEX is an essential nexus for protein export in malaria parasites. Nature 2014; 511: 587-91
34. Lopaticki S, Maier AG, Thompson J, et al. Reticulocyte and erythrocyte binding-like proteins function cooperatively in invasion of human erythrocytes by malaria parasites. Infect Immun 2011; 79: 1107-17
35. Maier AG, Cooke BM, Cowman AF, Tilley L. Malaria parasite proteins that remodel the host erythrocyte. Nat Rev Microbiol 2009; 7: 341-54
36. Osier FH, Feng G, Boyle MJ, et al. Opsonic phagocytosis of Plasmodium falciparum merozoites: mechanism in human immunity and a correlate of protection against malaria. BMC Med 2014; 12: 108
37. Wright KE, Hjerrild KA, Bartlett J, et al. Structure of malaria invasion protein RH5 with erythrocyte basigin and blocking antibodies. Nature 2014; 515(7527): 427-30